Filter
2469
Filtered Results: 2469
Text search:
Global
Health
Data
Exchange
Featured
Recommendations
170
New Publications
689
Language
Document type
No document type
1372
Studies & Reports
503
Guidelines
229
Strategic & Response Plan
138
Manuals
126
Fact sheets
34
Training Material
30
Situation Updates
24
Resource Platforms
4
Infographics
4
Brochures
2
Online Courses
2
Dashboards/Maps
1
Countries / Regions
Global
117
India
76
Kenya
64
Western and Central Europe
64
Ethiopia
60
Sierra Leone
52
Nigeria
51
Liberia
50
Ukraine
49
Syria
45
Myanmar / Burma
44
Africa
43
Uganda
42
Nepal
41
South Africa
38
Malawi
37
Latin America and the Carribbean
36
Rwanda
34
Zambia
32
Tanzania
30
Eastern Europe
27
Ghana
25
Bangladesh
25
Congo, Democratic Republic of
24
Asia
22
Philippines
21
South–East Asia Region
20
Indonesia
18
Lesotho
17
West and Central Africa
16
Namibia
16
Guinea
15
Haiti
15
Cambodia
15
Senegal
14
East and Southern Africa
14
Mozambique
13
Venezuela
13
Yemen
13
Middle East and North Africa
12
Russia
11
Cameroon
10
Zimbabwe
10
Jordan
10
Botswana
10
South Sudan
10
Pakistan
10
Afghanistan
9
Eastern Europe and Central Asia
9
Colombia
8
Thailand
8
Lebanon
8
Eswatini/ Swaziland
8
Albania
7
Germany
7
Western Pacific Region
7
Moldova
7
Tajikistan
6
Iran
6
Burkina Faso
6
Vietnam
6
Brazil
6
Sudan
6
Central African Republic
6
Somalia
6
Turkey
5
Laos
5
North Macedonia
4
Benin
4
China
4
Papua New Guinea
4
Chad
4
Iraq
4
Madagascar
4
Mexico
3
Croatia
3
Turkmenistan
3
Portugal
3
Spain
3
Côte d’Ivoire / Ivory Coast
3
Georgia
3
Mali
3
Angola
3
Libya
3
Timor Leste/ East Timor
2
Serbia
2
Gambia
2
Togo
2
Chile
2
Kyrgyzstan
2
Peru
2
Malaysia
2
Qatar
2
Armenia
2
Saudi Arabia
2
Paraguay
2
Jamaica
2
United Kingdom
2
Belarus
2
Bolivia
2
Egypt
2
Romania
2
Palestine
2
Honduras
2
Bhutan
2
Ecuador
2
El Salvador
1
Kazakhstan
1
Singapore
1
Morocco
1
Bulgaria
1
USA
1
Guinea-Bissau
1
Hungary
1
Lithuania
1
Japan
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Israel
1
Bosnia and Herzegovina
1
Southern Africa
1
Argentina
1
Sri Lanka
1
Djibouti
1
Greece
1
Poland
1
Authors & Publishers
Publication Years
Category
Countries
867
Public Health
153
Key Resources
129
Women & Child Health
128
Clinical Guidelines
108
Capacity Building
36
Pharmacy & Technologies
15
Annual Report MEDBOX
1
Toolboxes
HIV
236
COVID-19
188
Mental Health
151
Planetary Health
127
Disability
116
Conflict
111
TB
103
Rapid Response
74
AMR
69
Global Health Education
61
Ebola
60
Refugee
59
Pharmacy
58
Caregiver
50
Health Financing Toolbox
45
Natural Hazards
43
NTDs
38
NCDs
33
Polio
15
Specific Hazards
13
Zika
12
Social Ethics
7
Cholera
6
Health Financing
2
Typhoon
2
South Sudan
1
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance
Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ...
The Pandemic Influenza Preparedness (PIP) Framework is a World Health Assembly resolution adopted unanimously by all Member States in 2011. It brings together Member States, industry, other stakeholders and WHO to implement a global approach to pandemic influenza preparedness and response. The Frame...
WHO, in partnership with the International Society for Prosthetics and Orthotics (ISPO) and the United States Agency for International Development (USAID), has published global standards for prosthetics and orthotics. Its aim is to ensure that prosthetics and orthotics services are people-centred an...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
WHO, in partnership with the International Society for Prosthetics and Orthotics (ISPO) and the United States Agency for International Development (USAID), has published global standards for prosthetics and orthotics. Its aim is to ensure that prosthetics and orthotics services are people-centred an...
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr...
The threat posed by antimicrobial resistance (AMR) to public health as well as global health security has been reiterated in umerous World Health Assembly (WHA) resolutions. AMR is also prioritized under the Global Health Security Agenda (GHSA), and India is one of the contributing countries. The Mi...
AMR is one of the Key priority of the global health security agenda action package, as well as it is one of the commitments of Ministry of Public Health Afghanistan to combat AMR. In Afghanistan because of war and some other political issues the borders of the country are not well secured and well c...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
The Implementation toolkit for accessible telehealth services provides practical guidance to support governments, industry partners, health service providers and civil society groups in the use and implementation of the WHO-ITU Global standard for accessibility of telehealth services. The toolkit is...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
A resource for pesticide registrars and regulators.
The WHO urged governments to restrict access to highly toxic pesticides used for self-poisoning . Other effective interventions include education, youth intervention programs and follow-up of people at risk—and better data. Only 80 out of 183 WH...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
This document provides interim guidance for effective risk communication around Zika virus transmission and potential complications. A causal relationship between Zika virus infection and these potential complications has not yet been proven. In this uncertainty, effective communication strategies s...
